Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeurodigitX is a private digital health company developing a noninvasive platform to assess and monitor everyday systemic or metabolic inflammation using physiological signals rather than blood draws. Its offering combines a biosensor, heart rate variability and respiratory-rate analytics, and breath-controlled digital games to generate longitudinal inflammation-related biomarker data. The company positions its technology for consumer wellness, women's health, mental health, payvider monitoring, and use in clinical trials to track inflammatory response and behavior change over time. NeurodigitX appears to operate as a health-tech platform company rather than a therapeutics developer, and no conventional drug pipeline has been publicly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeurodigitX.